查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018806

醫療保健預測分析市場：按交付方式、部署方式和應用分類的全球市場預測 – 2026-2032 年

Healthcare Predictive Analytics Market by Offering, Deployment, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，醫療保健預測分析市場價值將達到 278.2 億美元，到 2026 年將成長至 353.1 億美元，到 2032 年將達到 1,493.2 億美元，複合年成長率為 27.12%。

主要市場統計數據
基準年 2025 278.2億美元
預計年份：2026年 353.1億美元
預測年份 2032 1493.2億美元
複合年成長率 (%) 27.12%

醫療保健預測分析策略架構：明確經營團隊重點、推動應用以及釋放臨床和營運價值所需的管治

醫療保健系統面臨一系列快速變化的壓力，包括慢性病盛行率上升、預算限制、監管日益複雜以及對品質和個人化服務日益成長的期望。預測分析逐漸成為一項策略功能，它將分散式資料來源與可執行的洞察聯繫起來，使醫療機構能夠從被動治療轉向主動管理。本文概述了領導者在臨床、財務和合規領域運行預測模型時必須應對的技術、人力資源和管治的變革。

技術成熟度、監管對可解釋性的重視以及不斷演變的營運模式如何重塑醫療保健分析領域的買方優先事項和部署策略。

過去幾年，在資料民主化、雲端原生架構以及監管機構日益關注結果的推動下，醫療保健分析領域已從孤立的先導計畫轉向企業級部署。這項變革性變化包括資料管道的成熟、對模型透明度日益成長的期望，以及從事後報告到即時決策支援的擴展應用場景。這些因素正在改變機構購買、建構和管治分析解決方案的方式。

本研究評估了近期關稅措施和貿易趨勢如何改變醫療保健分析基礎設施的採購成本、供應商選擇和部署方案。

近期關稅政策和貿易摩擦為醫療分析生態系統帶來了新的成本和供應鏈趨勢，尤其對硬體依賴元件和專用網路儲存設備而言更是如此。進口伺服器、網路設備和加速器關稅的增加導致成本上升，影響了採購時間和供應商選擇，促使各機構重新評估其總體擁有成本 (TCO) 和供應商多元化策略。

一個實用的細分框架，將具體的用例、軟體類型和服務模型與醫療保健提供者的實際整合和管治考慮因素聯繫起來。

精細化的細分觀點對於將分析能力轉化為跨用例、軟體類型和服務模式的實際價值至關重要。從應用角度來看，解決方案旨在應對感染疾病爆發預測、詐欺檢測與合規、患者風險評分、預防醫學和再入院預測等挑戰。在詐欺偵測與合規領域，演算法設計、資料需求和整合需求會因具體領域而異，例如保險詐欺偵測或監管合規。同樣，預防醫學也分為慢性病管理和健康管理兩大路徑，每個路徑都需要不同的縱向資料、病人參與能力和結果指標。

區域管理體制、公共衛生優先事項和採購架構如何影響全球醫療保健預測分析市場多樣化的採用路徑？

區域趨勢在預測分析的引入、監管和推廣方面發揮決定性作用。在美洲，相關人員面臨聯邦和州政策、充滿活力的私人醫療服務提供者和保險公司生態系統以及競爭激烈的供應商市場之間錯綜複雜的相互作用。這種環境推動了快速創新、活躍的創業投資活動，並日益重視基於結果的合約。因此，該地區的組織致力於擴展預測能力，以應用於人群健康、基於價值的醫療保健舉措以及保險公司方面的詐欺檢測。

供應商之間的關鍵競爭行為表明，可解釋性、臨床整合和以結果為導向的合約是長期採用和留住客戶的主要手段。

預測分析領域的供應商策略正趨向於幾個核心需求：提供可靠的模型、確保與臨床無縫整合以及提供強大的服務模式。主要企業正投資於模型的可解釋性、強大的檢驗框架以及與臨床網路的合作，以產生臨床療效的證據。這些投資降低了採用門檻，並基於結果而非功能清單創造了引人注目的差異化優勢。

為高階管理層提供切實可行的、高優先級的行動方案，以加速利用預測分析創造價值，同時降低營運風險並確保臨床可靠性。

產業領導企業應優先考慮能夠加速部署並同時管控風險的實際的投資。首先，應明確高影響力、規模有限的應用情境——例如，利用患者風險評分進行精準護理管理，或透過詐欺檢測來保護收入——並制定與這些試點計畫相關的可衡量的臨床和營運成功標準。這種方法能夠集中資源，並建立循證基礎，從而支持更廣泛的部署。

高度透明的研究途徑，結合與關鍵相關人員的訪談、主題性二手資料和交叉檢驗，可以產生可重複的、以實踐者為中心的見解。

本分析所依據的研究結合了第一手質性研究成果和嚴謹的二手研究，並採用透明的調查方法，旨在幫助高階決策者有效利用研究結果。第一手研究包括對臨床負責人、資訊長、分析負責人和解決方案供應商進行結構化訪談，以了解實際部署經驗、挑戰和成功因素。這些訪談旨在揭示與永續部署相關的管治模式、整合方法和服務協議。

嚴格的管治、有針對性的試點部署以及與臨床醫生的夥伴關係是決定預測分析能否帶來永續的臨床和營運價值的關鍵因素。

預測分析是現代醫療機構的關鍵功能，但僅靠演算法效能不足以充分發揮其潛力。成功需要臨床、技術和管治領域的跨部門協作，明確用例的優先級，以及反映營運實際情況和監管限制的採購模式。經過嚴格檢驗並與臨床醫生共同設計後實施的預測工具，能夠支援早期療育、減少低效並提高合規性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：醫療保健預測分析市場：依產品/服務分類

  • 軟體
  • 服務

第9章：醫療保健預測分析市場：依部署方式分類

  • 基於雲端的
  • 現場

第10章：醫療保健預測分析市場：按應用領域分類

  • 疾病爆發預測
  • 詐欺偵測與合規
    • 保險詐欺偵測
    • 監理合規
  • 患者風險評分
  • 預防醫學
    • 慢性病管理
    • 健康管理
  • 預測再入院率

第11章：醫療保健預測分析市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第12章：醫療保健預測分析市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章 醫療保健預測分析市場：按國家/地區分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章：美國醫療保健預測分析市場

第15章：中國醫療預測分析市場

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Allscripts Healthcare Solutions, Inc.
  • Alteryx
  • Apixio, Inc.
  • Arcadia Solutions, LLC
  • Athenahealth, Inc.
  • Cerner Corporation
  • Cisco Systems, Inc.
  • CitiusTech Inc.
  • Clarify Health Solutions, Inc.
  • ClosedLoop.ai Inc.
  • Cloudticity, LLC
  • Cotiviti, Inc.
  • Epic Systems Corporation
  • GE HealthCare Technologies Inc.
  • Google LLC by Alphabet Inc.
  • Health Catalyst, Inc.
  • HealthVerity, Inc.
  • HOKUTO Inc.
  • Inovalon Holdings, Inc.
  • International Business Machines Corporation
  • IQVIA Inc.
  • Koninklijke Philips NV
  • McKesson Corporation
  • MedeAnalytics, Inc.
  • Microsoft Corporation
  • Optum, Inc.
  • Oracle Corporation
  • RIB Datapine GmbH
  • SAP SE
  • SAS Institute Inc.
  • Veradigm LLC
  • Verinovum
  • Virgin Pulse
  • Wipro
Product Code: MRR-ED54C46E8630

The Healthcare Predictive Analytics Market was valued at USD 27.82 billion in 2025 and is projected to grow to USD 35.31 billion in 2026, with a CAGR of 27.12%, reaching USD 149.32 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 27.82 billion
Estimated Year [2026] USD 35.31 billion
Forecast Year [2032] USD 149.32 billion
CAGR (%) 27.12%

A strategic framing of predictive analytics in healthcare that clarifies executive priorities, adoption drivers, and the governance needed to unlock clinical and operational value

Healthcare systems are navigating a rapidly evolving set of pressures-rising chronic disease prevalence, constrained budgets, regulatory complexity, and heightened expectations for quality and personalization. Predictive analytics has emerged as a strategic capability that connects disparate data sources to actionable foresight, enabling organizations to shift from reactive care to proactive management. This introduction frames the technology, workforce, and governance shifts leaders must address to operationalize predictive models across clinical, financial, and compliance domains.

Adoption is less about technology alone and more about aligning analytics with clinical workflows, data governance, and change management. Interoperability, model explainability, and clinician trust determine whether predictive outputs influence decisions at the point of care. Equally important are organizational structures that support continuous model validation, privacy-preserving data practices, and cross-functional accountability. When these elements converge, institutions can realize improvements in patient outcomes, cost efficiency, and regulatory resilience.

This section sets expectations for the analysis that follows, outlining how applications such as disease outbreak prediction, fraud detection and compliance, patient risk scoring, preventive care, and readmission prediction interact with platforms, services, and regional policy dynamics. It also previews the strategic actions that leaders can take to translate analytic potential into validated operational impact.

How technological maturation, regulatory emphasis on explainability, and evolving operational models are reshaping buyer priorities and deployment strategies in healthcare analytics

Over the past several years, the healthcare analytics landscape has shifted from isolated pilot projects to enterprise-grade deployments driven by a confluence of data democratization, cloud-native architectures, and regulatory emphasis on outcomes. The transformative shifts include maturation of data pipelines, rising expectations for model transparency, and an expanding set of use cases that move beyond retrospective reporting to real-time decision support. These forces are changing how organizations buy, build, and govern analytic solutions.

Technology advances have lowered barriers to entry: platform providers now offer integrated services that combine scalable compute with native data protection features, while tools for model development and monitoring facilitate continuous performance assessment. At the same time, stakeholders demand models that are interpretable and auditable, prompting investments in explainability tools and governance frameworks. Operationally, teams are reorganizing-bringing together clinicians, data scientists, and compliance officers to ensure analytics shape care pathways rather than creating parallel workflows.

As deployment scales, interoperability and vendor consolidation become central considerations. Organizations must weigh the benefits of integrated platforms against the flexibility of specialized tools, and they must plan for long-term maintainability and regulatory scrutiny. The cumulative effect of these shifts is a health analytics landscape that rewards disciplined governance, clinical partnership, and pragmatic technology choices.

Assessing how recent tariff measures and trade dynamics are altering procurement costs, supplier selection, and deployment choices for healthcare analytics infrastructure

Recent tariff policies and trade tensions have introduced new cost and supply-chain dynamics into the healthcare analytics ecosystem, especially for hardware-dependent components and specialized networking and storage equipment. Tariff-driven cost increases for imported servers, networking appliances, and accelerators can influence procurement timing and vendor selection, prompting organizations to reassess total cost of ownership and supplier diversification strategies.

Beyond hardware, tariffs can indirectly affect software procurement because vendors may reprice hosted services or alter regional data-center footprints in response to higher operational costs. Procurement teams are increasingly evaluating on-premises versus cloud trade-offs through the lens of geopolitical risk, latency, and regulatory constraints. For some buyers, tariffs accelerate the shift toward subscription-based cloud offerings that reduce upfront capital outlay but require rigorous scrutiny of data residency and contractual protections.

In aggregate, the tariff environment is encouraging healthcare organizations and vendors to pursue more resilient supply chains, adopt flexible deployment models, and prioritize vendors that demonstrate transparent cost structures and regional service continuity. These adjustments aim to preserve roadmap commitments to analytics capabilities while mitigating the financial and operational uncertainty introduced by evolving trade policies.

An actionable segmentation framework that links specific use cases, software types, and service models to practical integration and governance considerations for healthcare providers

A refined segmentation lens is essential for translating analytics capability into targeted value across use cases, software types, and service models. When viewed through the application axis, solutions address disease outbreak prediction, fraud detection and compliance, patient risk scoring, preventive care, and readmission prediction. Within fraud detection and compliance, specializations such as insurance fraud detection and regulatory compliance alter algorithm design, data requirements, and integration needs; similarly, preventive care splits into chronic disease management and wellness management pathways, each demanding different longitudinal data, patient-engagement capabilities, and outcome measures.

On the software front, a clear distinction exists between platforms and tools. Comprehensive platforms typically bundle data ingestion, storage, model execution, and monitoring to support enterprise-wide deployments, while focused tools offer deep capabilities for model development, explainability, or clinical integration that are often embedded into platform workflows. This differentiation influences procurement strategies, interoperability planning, and total-cost considerations.

Service segmentation further shapes execution risk and speed to value; consulting engagements help define strategy and use-case prioritization, integration and implementation teams execute technical and workflow integration, and support and maintenance services ensure model life-cycle management and operational continuity. Organizations that align their application priorities with the right mix of platforms, tools, and services stand the best chance of accelerating adoption while maintaining clinical safety and compliance.

How distinct regional regulatory regimes, public health priorities, and procurement architectures are shaping divergent adoption pathways for predictive analytics across global healthcare markets

Regional dynamics play a determinative role in how predictive analytics is adopted, regulated, and scaled. In the Americas, stakeholders face a complex interplay of federal and state policies, a vibrant private-sector provider and payer ecosystem, and a highly competitive vendor marketplace; these conditions favor rapid innovation, strong venture-backed activity, and an emphasis on outcomes-based contracting. Consequently, organizations in this region concentrate on scaling predictive capabilities for population health, value-based care initiatives, and payer-side fraud detection.

Across Europe, the Middle East, and Africa, regulatory frameworks and data-protection regimes vary widely, which shapes decisions around data residency, cross-border analytics, and vendor selection. In several markets, strong public-sector investment in national health data infrastructures enables large-scale deployments of disease surveillance and predictive risk scoring, while other jurisdictions emphasize certification, explainability, and procurement diligence before wide adoption.

The Asia-Pacific region exhibits a mix of rapid digital adoption and diverse regulatory maturity. Some countries have advanced national digital health programs and extensive telehealth adoption that accelerate preventive care and chronic disease management analytics, while others are focused on modernizing foundational data infrastructure. Regional variation in cloud policy, talent availability, and public-private collaboration models results in differentiated pathways to scaling analytics solutions.

Key competitive behaviors among vendors demonstrate why explainability, clinical integration, and outcome-oriented contracts are the primary levers for long-term adoption and retention

Vendor strategies in the predictive analytics space are converging around a few core imperatives: deliver trustworthy models, ensure seamless clinical integration, and offer resilient service models. Leading companies are investing in model explainability, robust validation frameworks, and partnerships with clinical networks to generate evidence of clinical efficacy. These investments reduce adoption friction and create defensible differentiation grounded in outcomes rather than feature lists.

Some vendors prioritize integrated platform offerings that simplify data ingestion, model deployment, and ongoing monitoring, appealing to enterprise buyers seeking standardized governance. Others focus on specialized tools that address niche requirements-such as insurance fraud detection algorithms or chronic disease management patient-engagement modules-and these specialists often partner with platform providers or system integrators to reach scale. Across the ecosystem, managed services and outcome-based contracts are becoming more common as buyers seek predictable operational performance and reduced internal burden.

Strategic activity also includes alliances with cloud providers, EMR vendors, and consulting firms to embed analytics into clinical and administrative workflows. Companies that demonstrate transparent validation, compliance readiness, and operational support capabilities are more likely to sustain long-term relationships with health systems and payers.

Practical and prioritized actions for executives to accelerate value extraction from predictive analytics while reducing operational risk and ensuring clinical trust

Industry leaders should prioritize pragmatic investments that accelerate adoption while managing risk. Begin by defining a limited set of high-impact use cases-such as patient risk scoring for targeted care management or fraud detection to protect revenue-and create measurable clinical and operational success criteria tied to those pilots. This approach concentrates resources and builds an evidence base that supports broader rollout.

Next, establish rigorous governance around data quality, model validation, and clinician engagement. Governance should codify responsibilities for model performance monitoring, incident response, and periodic revalidation, and it should include clinicians in acceptance testing to ensure outputs are trusted and actionable. Concurrently, invest in interoperability and integration work to embed predictive outputs into clinician workflows and administrative systems; minimal friction at the point of decision increases uptake and sustained use.

Finally, adopt flexible procurement and partnership models that account for evolving regulatory and supply-chain environments. Consider modular architectures that allow mixing platform capabilities with best-of-breed tools, and favor service agreements that include continual validation and support. By executing with disciplined pilots, strong governance, and adaptive procurement, organizations can de-risk adoption and accelerate measurable impact.

A transparent research approach that integrates primary stakeholder interviews, thematic secondary synthesis, and cross-validation to produce reproducible and practitioner-focused insights

The research underpinning this analysis combines primary qualitative insights with rigorous secondary synthesis and methodological transparency to ensure findings are actionable for executive decision-makers. Primary research included structured interviews with clinical leaders, CIOs, analytics directors, and solution providers to capture real-world deployment experiences, pain points, and success factors. These interviews were instrumented to surface governance models, integration approaches, and service arrangements that correlate with sustained adoption.

Secondary research entailed a thematic review of recent regulatory developments, technical advances in model explainability and monitoring, and publicly available case studies that document clinical and operational outcomes. Data collection focused on observable practices and verifiable programmatic details rather than proprietary performance metrics. Analysis employed a cross-validation approach: triangulating interview insights, vendor documentation, and operational case evidence to identify consistent patterns and risks.

Throughout, methodological safeguards addressed bias and ensured reproducibility. Sources were assessed for relevance and recency, interview samples were selected to represent diverse stakeholder perspectives, and findings were peer-reviewed to confirm internal consistency. The final synthesis prioritizes practical guidance over speculative projection and highlights implementable pathways for organizations pursuing predictive analytics.

A concise synthesis of how disciplined governance, targeted pilots, and clinician partnership determine whether predictive analytics deliver enduring clinical and operational value

Predictive analytics represents a pivotal capability for modern healthcare organizations, but realizing its promise depends on more than algorithmic performance. Success requires alignment among clinical, technical, and governance domains; clear use-case prioritization; and procurement models that reflect operational realities and regulatory constraints. When deployed with rigorous validation and clinician co-design, predictive tools can support earlier interventions, reduce inefficiencies, and enhance compliance.

The sectors that will capture the most value are those that combine focused pilots with scalable governance: prioritizing a narrow set of measurable use cases, embedding outputs into existing workflows, and maintaining continuous validation and stakeholder engagement. Equally, organizations that neglect data quality, explainability, or integration will struggle to convert analytic insight into sustained operational outcomes.

In conclusion, the journey from experimentation to enterprise deployment is achievable with disciplined execution, pragmatic procurement, and persistent clinical partnership. Stakeholders who act now to harmonize data, governance, and integration will be best positioned to deliver demonstrable improvements in patient care and organizational efficiency.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Healthcare Predictive Analytics Market, by Offering

  • 8.1. Software
  • 8.2. Services

9. Healthcare Predictive Analytics Market, by Deployment

  • 9.1. On-cloud
  • 9.2. On-premise

10. Healthcare Predictive Analytics Market, by Application

  • 10.1. Disease Outbreak Prediction
  • 10.2. Fraud Detection & Compliance
    • 10.2.1. Insurance Fraud Detection
    • 10.2.2. Regulatory Compliance
  • 10.3. Patient Risk Scoring
  • 10.4. Preventive Care
    • 10.4.1. Chronic Disease Management
    • 10.4.2. Wellness Management
  • 10.5. Readmission Prediction

11. Healthcare Predictive Analytics Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Healthcare Predictive Analytics Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Healthcare Predictive Analytics Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. United States Healthcare Predictive Analytics Market

15. China Healthcare Predictive Analytics Market

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025
  • 16.5. Allscripts Healthcare Solutions, Inc.
  • 16.6. Alteryx
  • 16.7. Apixio, Inc.
  • 16.8. Arcadia Solutions, LLC
  • 16.9. Athenahealth, Inc.
  • 16.10. Cerner Corporation
  • 16.11. Cisco Systems, Inc.
  • 16.12. CitiusTech Inc.
  • 16.13. Clarify Health Solutions, Inc.
  • 16.14. ClosedLoop.ai Inc.
  • 16.15. Cloudticity, L.L.C
  • 16.16. Cotiviti, Inc.
  • 16.17. Epic Systems Corporation
  • 16.18. GE HealthCare Technologies Inc.
  • 16.19. Google LLC by Alphabet Inc.
  • 16.20. Health Catalyst, Inc.
  • 16.21. HealthVerity, Inc.
  • 16.22. HOKUTO Inc.
  • 16.23. Inovalon Holdings, Inc.
  • 16.24. International Business Machines Corporation
  • 16.25. IQVIA Inc.
  • 16.26. Koninklijke Philips N.V.
  • 16.27. McKesson Corporation
  • 16.28. MedeAnalytics, Inc.
  • 16.29. Microsoft Corporation
  • 16.30. Optum, Inc.
  • 16.31. Oracle Corporation
  • 16.32. RIB Datapine GmbH
  • 16.33. SAP SE
  • 16.34. SAS Institute Inc.
  • 16.35. Veradigm LLC
  • 16.36. Verinovum
  • 16.37. Virgin Pulse
  • 16.38. Wipro

LIST OF FIGURES

  • FIGURE 1. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY OFFERING, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY DEPLOYMENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. UNITED STATES HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 11. CHINA HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY ON-CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY ON-CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY ON-CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY ON-PREMISE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY ON-PREMISE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY DISEASE OUTBREAK PREDICTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY DISEASE OUTBREAK PREDICTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY DISEASE OUTBREAK PREDICTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY FRAUD DETECTION & COMPLIANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY FRAUD DETECTION & COMPLIANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY FRAUD DETECTION & COMPLIANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY FRAUD DETECTION & COMPLIANCE, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY INSURANCE FRAUD DETECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY INSURANCE FRAUD DETECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY INSURANCE FRAUD DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY REGULATORY COMPLIANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY REGULATORY COMPLIANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY REGULATORY COMPLIANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY PATIENT RISK SCORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY PATIENT RISK SCORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY PATIENT RISK SCORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY PREVENTIVE CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY PREVENTIVE CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY PREVENTIVE CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY PREVENTIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY WELLNESS MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY WELLNESS MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY WELLNESS MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY READMISSION PREDICTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY READMISSION PREDICTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY READMISSION PREDICTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. AMERICAS HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 48. AMERICAS HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 49. AMERICAS HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY FRAUD DETECTION & COMPLIANCE, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY PREVENTIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 53. NORTH AMERICA HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. NORTH AMERICA HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 55. NORTH AMERICA HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY FRAUD DETECTION & COMPLIANCE, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY PREVENTIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 59. LATIN AMERICA HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. LATIN AMERICA HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 61. LATIN AMERICA HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY FRAUD DETECTION & COMPLIANCE, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY PREVENTIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY FRAUD DETECTION & COMPLIANCE, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY PREVENTIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY FRAUD DETECTION & COMPLIANCE, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY PREVENTIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 77. MIDDLE EAST HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. MIDDLE EAST HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 79. MIDDLE EAST HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 80. MIDDLE EAST HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. MIDDLE EAST HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY FRAUD DETECTION & COMPLIANCE, 2018-2032 (USD MILLION)
  • TABLE 82. MIDDLE EAST HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY PREVENTIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 83. AFRICA HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. AFRICA HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 85. AFRICA HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 86. AFRICA HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. AFRICA HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY FRAUD DETECTION & COMPLIANCE, 2018-2032 (USD MILLION)
  • TABLE 88. AFRICA HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY PREVENTIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY FRAUD DETECTION & COMPLIANCE, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY PREVENTIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. ASEAN HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. ASEAN HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 98. ASEAN HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 99. ASEAN HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. ASEAN HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY FRAUD DETECTION & COMPLIANCE, 2018-2032 (USD MILLION)
  • TABLE 101. ASEAN HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY PREVENTIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 102. GCC HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GCC HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 104. GCC HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 105. GCC HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. GCC HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY FRAUD DETECTION & COMPLIANCE, 2018-2032 (USD MILLION)
  • TABLE 107. GCC HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY PREVENTIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPEAN UNION HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPEAN UNION HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPEAN UNION HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPEAN UNION HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPEAN UNION HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY FRAUD DETECTION & COMPLIANCE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPEAN UNION HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY PREVENTIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 114. BRICS HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. BRICS HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 116. BRICS HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 117. BRICS HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. BRICS HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY FRAUD DETECTION & COMPLIANCE, 2018-2032 (USD MILLION)
  • TABLE 119. BRICS HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY PREVENTIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 120. G7 HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. G7 HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 122. G7 HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 123. G7 HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. G7 HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY FRAUD DETECTION & COMPLIANCE, 2018-2032 (USD MILLION)
  • TABLE 125. G7 HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY PREVENTIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 126. NATO HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. NATO HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 128. NATO HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 129. NATO HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. NATO HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY FRAUD DETECTION & COMPLIANCE, 2018-2032 (USD MILLION)
  • TABLE 131. NATO HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY PREVENTIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. UNITED STATES HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 134. UNITED STATES HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 135. UNITED STATES HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 136. UNITED STATES HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. UNITED STATES HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY FRAUD DETECTION & COMPLIANCE, 2018-2032 (USD MILLION)
  • TABLE 138. UNITED STATES HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY PREVENTIVE CARE, 2018-2032 (USD MILLION)
  • TABLE 139. CHINA HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. CHINA HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 141. CHINA HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY DEPLOYMENT, 2018-2032 (USD MILLION)
  • TABLE 142. CHINA HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. CHINA HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY FRAUD DETECTION & COMPLIANCE, 2018-2032 (USD MILLION)
  • TABLE 144. CHINA HEALTHCARE PREDICTIVE ANALYTICS MARKET SIZE, BY PREVENTIVE CARE, 2018-2032 (USD MILLION)